15 results
6-K
EX-99.1
SNY
Sanofi
27 Oct 23
Specialty Care growth, strong launch uptake of Beyfortus® and ALTUVIIIO® drive solid Q3 results
12:39pm
% of renewable electricity in all our sites by 2030
Eco-car fleet
100% carbon neutral car fleet in 2030
39.8% eco fleet
36.5% eco fleet
Blister free syringe
6-K
EX-99.1
SNY
Sanofi
27 Sep 23
Current report (foreign)
6:06am
, are carbon-neutral by design, with zero landfilling and 100% of the waste recycled or recovered.
Several pilot programs have also been conducted to assess
6-K
EX-99.1
SNY
Sanofi
28 Oct 22
Continued strong growth in Q3 with key regulatory milestones achieved
11:16am
100% electricity from renewable sources and the Company has set a target of a carbon-neutral for its car fleet, both by 2030.Planet Care
Blister free
6-K
EX-99.1
SNY
Sanofi
28 Jul 22
Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease
10:12am
% electricity from renewable sources and the Company has set a target of a carbon-neutral for its car fleet, both by 2030.
Planet Care
Blister free
6-K
EX-99.1
SNY
Sanofi
28 Apr 22
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1
12:16pm
renewable sources and the Company has set a target of a carbon-neutral for its car fleet, both by 2030.
Dashboard for planet
Blister free vaccines
FY
6-K
EX-99.1
nw41vygluoby3 o2z
4 Feb 22
Strong 2021 sales and business EPS(1) growth enabling increased investment in R&D
9:56am
6-K
EX-99.1
1lik7k6
28 Oct 21
Q3 2021 sales grew double digit to €10.4 billion (up 10.1%) due to strong growth from Dupixent®, Vaccines and CHC
11:19am
6-K
EX-99.3
84ecd
8 Jun 21
Sanofi launches its new global employee share ownership plan
1:31pm
6-K
EX-99.4
e7dq831eitvf2
13 Apr 21
Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities
2:56pm
6-K
EX-99.1
xqds32tm
13 Apr 21
Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities
2:56pm
- Prev
- 1
- Next